PALO ALTO, Calif., Oct. 13, 2015 /PRNewswire/ -- Varian Medical Systems, Inc., (NYSE: VAR) today announced plans to offer cancer centers a powerful new interactive software engine that will enable radiation oncologists to quickly create, review and optimize radiotherapy and radiosurgery dose prescriptions for their patients. The company has acquired HyperDrive™ software technology that will be further developed to both improve the quality of prescriptions and accelerate the treatment planning process.
HyperDrive was developed by Karl Otto, adjunct professor of medical physics at the University of British Columbia, who was also instrumental in the development of Varian's RapidArc® radiotherapy, which expedited delivery of high-precision intensity-modulated radiation therapy.
"HyperDrive is real-time, interactive technology that will enable physicians to assess a large number of treatment options in only a few minutes. They will be able to evaluate the trade-offs between different strategies for maximizing dose to a tumor while reducing doses to nearby tissues and organs," Otto said. "Once physicians have used HyperDrive to find the optimal dose distribution for their patients, they will be able to generate an electronic treatment prescription that contains more information about the physician's intent than was possible before."
Ad Statistics
Times Displayed: 21862
Times Visited: 433 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
"HyperDrive will be a powerful complement to the RapidPlan® software, which uses prior knowledge to help clinical teams produce higher quality treatment plans," said Corey Zankowski, vice president, product and strategic portfolio management. "Combining HyperDrive with RapidPlan will let physicians create extremely refined 3-D prescriptions in minutes. This combination should result in better treatment plans with fewer back-and-forth consultations between the physician and the dosimetrist who creates the treatment plan based on the physician's prescription."
Varian plans to integrate the HyperDrive technology into the company's market-leading Eclipse™ treatment planning system, which is in use at some 3,400 cancer treatment centers around the world. It will be made available for sale in conjunction with Eclipse and RapidPlan. Eclipse was named "Category Leader" in the 2014 and 2013 "Best in KLAS: Software and Services Report" from KLAS, a research firm that specializes in monitoring and reporting on the performance of healthcare vendors.
